Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2025-12-25 @ 1:33 AM
NCT ID:
NCT00239694
Eligibility Criteria:
Inclusion Criteria:
* Enrolled in the BLSA with at least 2 stored blood samples post vaccination
* 65 years old or older
* Previously vaccinated with Pneumovax at least 5 years ago or never vaccinated
* Willing to receive vaccination with pneumococcal and meningococcal injection
* Able to provide informed consent
* Has never received a meningococcal vaccine
Exclusion Criteria:
* Hypersensitivity to the pneumococcal or meningococcal vaccine
* Ever received the Meningococcal vaccine
* History of non-skin cancer
* History of myeloproliferative disorder
* History of HIV
* Received a Bone Marrow Transplant
* Taking prednisone (more than 5 mg/day) or other immunosuppressive medication
* Evidence of severe liver or renal disease (serum creatine \>2.0 mg/dL or Total Bilirubin \>2.0
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT00239694
Study Brief:
Protocol Section:
NCT00239694